Fortune, April 7, 2021. There’s a big problem with clinical trials: a lack of diversity. This problem led researchers to believe that Black women did not develop breast cancer as frequently as white women and created a gap in understanding how different treatments work. How can companies like Genentech start increasing diversity in clinical trials?
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
The FDA Cut Off COVID Vaccine Testing. That Was a Really Bad Idea.
Washington Monthly, March 26, 2021: Not since the polio vaccine became available in April 1955 have Americans been so excited about getting a shot. But behind the scenes, there’s a lot we don’t know because of a decision made back in December by the FDA. The agency allowed manufacturers to effectively stop their clinical trials as soon as they were authorized to market their vaccines, making it impossible to learn how long the vaccines work and for whom.
Read More »‘Buyer beware’: Ads hide PFAS cookware risks
E & E News, March 24, 2021: Consumers trying to avoid toxic chemicals in their nonstick cookware face convoluted advertising claims that can confuse even the most well-informed buyers. Take Diana Zuckerman, who, as president of the National Center for Health Research, is more familiar than the average person with chemistry and toxicology. Still, she said, trying to determine which pans and cookware did not contain PFAS, a class of toxic substances linked to cancer and other health problems, was no easy task.
Read More »Avoiding the Subject: On Pfizer Vaccine Quality Control, FDA Says Less than European Counterpart
Project on Government Oversight, March 19, 2021: The Project on Government Oversight’s new report about the Pfizer COVID Vaccine raises questions about why the FDA did not publicly disclose quality control concerns that were publicly raised in Europe. We ask: Is “adequate” quality control good enough?
Read More »Birth Control Apps Show the Contradictions in FDA Device Oversight
The Verge, March 17, 2021: The FDA has allowed a second digital birth control app to be sold in the U.S. Neither Natural Cycles nor Clue were tested in clinical trials. NCHR asks how safe and effective are they, and are women being misled?
Read More »